Peppermint VenturePartners
Also known as PVP, Peppermint Venture Partners, Peppermint VenturePartners GmbH, Peppermint Charité Biomedical Fund
Berlin life-science VC grown out of Peppermint Holding; manages Peppermint CBF 1 (EUR 30m, 2011, with Charité) and is raising the EUR 100m-target LIIDO lab-tech fund.
Berlin life-science VC (pvp.health); its sister company PVP Advisors is an advisory firm, not a fund.
- HEADQUARTERS
- Berlin, Germany
- FOUNDED
- 2010
- AUM
- —
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 5 people
FOCUS
- STAGES
- SeedSeries A
- ASSET MIX
- Venture capital
- GEOGRAPHY
- EuropeGermanyAustriaSwitzerlandUnited Kingdom
WHAT IT IS
VC Fund. A fund manager investing capital raised from limited partners into startups.
- Sister company providing financial, management and strategic advice to research institutions and start-ups; external manager of the Helmholtz Validation Fund
ABOUT
Peppermint VenturePartners (PVP) is a Berlin venture capital firm that grew out of Peppermint Holding, the Berlin textile industry group founded by Ingeborg Neumann, which launched its first venture fund (VC 1, EUR 21m) in 2000. PVP was relaunched as an independent fund manager in 2010 and runs Peppermint CBF 1 GmbH & Co. KG, a EUR 30m early-stage healthcare fund (vintage 2011) built on a partnership with the Charité. Its planned LIIDO fund targets EUR 100m for life-science tools and services companies with initial revenues in Europe, with a focus on DACH, the UK and Scandinavia.
INVESTMENT THESIS
Technology-driven early-stage life-science companies, especially life science tools & services (LabTech), with market traction and initial revenues; solutions bringing efficiency, accessibility, cost containment and digitisation to healthcare; Europe with a focus on DACH, UK and Scandinavia; hands-on capability building through Entrepreneurs in Residence.
PORTFOLIO (11)
- CEVEC PharmaceuticalsNOTABLEBiotech & Life Sciences · since 2012 · Exited
- ScienionNOTABLEBiotech & Life Sciences · Exited (trade sale; now a BICO company)
- HealthTech · since 2014 · Active
- HealthTech · since 2013 · Active
- HealthTech · since 2012 · Active
- Implandata Ophthalmic ProductsHealthTech · Listed in CBF-1 portfolio (team bio)
- HealthTech · since 2016 · Active
- HealthTech · since 2011 · Exited
- HealthTech · since 2013 · Exited
- LabforwardSoftware & SaaS · since 2015 · Exited (merged with LabTwin, 2024)
- CellAct PharmaBiotech & Life Sciences · Exited (drug candidate sold to Mundipharma)
TEAM
- Ingeborg NeumannCo-founder and Managing Partner; Managing Director (Impressum); founder of Peppermint Holding · source
- Dr. Joachim RautterCo-founder and Managing Partner; Managing Director (Impressum) · source
- Dr. Klaus StöckemannCo-founder and Managing Partner; Managing Director (Impressum) · source
- Dr. Magnus HolmVenture Partner (since 2012) · source
- Simone SchöppDirector Finance · source
LINKS
FAQ
Peppermint VenturePartners is a VC fund based in Berlin, Germany, founded in 2010.
Yes. Peppermint VenturePartners invests directly in private companies.
Peppermint VenturePartners invests at Seed and Series A stages in HealthTech and Biotech & Life Sciences.
Key people at Peppermint VenturePartners include Ingeborg Neumann (Co-founder and Managing Partner; Managing Director (Impressum); founder of Peppermint Holding), Dr. Joachim Rautter (Co-founder and Managing Partner; Managing Director (Impressum)), Dr. Klaus Stöckemann (Co-founder and Managing Partner; Managing Director (Impressum)) and Dr. Magnus Holm (Venture Partner (since 2012)).
Peppermint VenturePartners's investments include CEVEC Pharmaceuticals, Scienion, Caterna Vision, CryoTherapeutics, G-Metrics, Implandata Ophthalmic Products, Miracor Medical and Humedics, among others.
The most recent publicly reported investment by Peppermint VenturePartners is Miracor Medical (First investment (CBF 1 fund)), announced in Oct 2016.
Peppermint VenturePartners states that it does not accept unsolicited proposals.
Yes. Peppermint VenturePartners manages capital from outside investors.